Johnson & Johnson Aktie News

MILFORD, Conn.--(BUSINESS WIRE)-- #SOC2--PBIRx, a pharmacy benefits consulting and auditing firm, sees growth from concerns over alleged fiduciary breach lawsuit against Johnson & Johnson.

In the changing environment of 2024, astute investors have a plethora of options to strengthen their financial portfolios strategically by purchasing dividend stocks. These prospects result from industry titans' forward-thinking initiatives and solid performance.

Altria offers an outsized dividend with little risk of a cut. Johnson & Johnson isn't flashy, but it's a bargain you shouldn't pass up.

Not all stocks have succeeded in the bull market that began about 18 months ago. In the current market, a rising tide has not lifted all boats.

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will participate in the Bernstein's 40th Annual Strategic Decisions Conference (SDC) on Wednesday, May 29th, at the New York Hilton Midtown, New York, NY. Joaquin Duato, Chairman and Chief Executive Officer will represent the Company in a session scheduled at 1:30 pm (Eastern Time). This live audio webcast will be available to ...

Johnson & Johnson stock has continued to underperform the healthcare sector, worrying JNJ investors. JNJ's potentially massive talc-related legal liabilities will likely affect buying sentiment. However, it's easy to forget that JNJ is a fundamentally strong business with robust free cash flow profitability.

In February, I recommended five one-month momentum plays to buy as Bitcoin ( BTC-USD ) prices surged. The world's largest cryptocurrency is a surprisingly good gauge of bubbly investor sentiment, and our writers at InvestorPlace.com had found several strong candidates to ride the market higher.

2023 was up 24%. 3 months down in 2024 and the S&P 500 is already up 6%, down from the plus 10% they were at.